Ceretek LLC
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Ceretek LLC
Ceretek LLC
Ceretek LLC is developing new cancer therapeutic targets based on endothelial differentiation gene (Edg) receptors, a subtype of lipid GPCRs that have been shown to be up-regulated in a variety of cancers. The company has proprietary assays for all eight Edg receptors, and is developing drug candidates based on the targets it identifies.
Start-Up Previews (11/02)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The Future of Memory Disorders, features profiles of Accera Inc., GBtherapeutics Ltd., Saegis Pharmaceuticals Inc. and Sention Inc. Plus these selected Start-Ups across Health Care: Anosys Inc., Ceretek LLC, Fossa Medical Inc. and Peoples Genetics Inc.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice